BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ICC - ECPv5.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ICC
X-ORIGINAL-URL:https://ouricc.org
X-WR-CALDESC:Events for ICC
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20210501T100000
DTEND;TZID=UTC:20210501T113000
DTSTAMP:20260406T141707
CREATED:20210507T095504Z
LAST-MODIFIED:20210514T101920Z
UID:6545-1619863200-1619868600@ouricc.org
SUMMARY:Preventing Type 2 Diabetes – From Theory to Reality
DESCRIPTION:According to the Center for Disease Control\, 1 in 3 adults in the USA are prediabetics (over 88 million). And 80% of them don’t even know they have it! Many people with prediabetes could develop type 2 diabetes within 5 years if they don’t do anything about it. \nElevated glycemic markers are a major risk factor for heart disease\, which is the most common cause of death among adults with diabetes mellitus. \nSouth Asians Double Jeopardy \n\nDiabetes is 2 to 4 times more prevalent amongst South Asians.\nSouth Asians develop diabetes 10 to 15 years earlier than Caucasians.\n\nAnd 80% of diabetics die of heart disease \nYou may have heard that before\, but the risks of this illness can be mitigated or even reversed. It’s true! \nCome join us for a FREE Educational Webinar that contrasts reality and theory \nPreventing type 2 Diabetes: From Theory to Reality\nBy Dr. Vanita Aroda\, Director\, Diabetes Clinical Research\, Brigham and Women’s Hospital\, Harvard Medical School\nand \nAIM to Prevent program\nBy Mr. Amit Akkad\, Director ICC and Lifestyle Program Ambassador\non Saturday\, May 1st\, 2021\, at 10 AM Eastern US time \nWhat you will learn \n\nUnderstand the evidence behind lifestyle intervention or metformin in the prevention of type 2 diabetes\nKnow long-term effects of efforts to prevent type 2 diabetes\nLearn about the relationship between blood sugar control and long-term cardiovascular health\nPractical ideas based on science\n\nRegistration is required to attend. Please click here to register \nSpeakers for this webinar\nDr. Vanita Aroda\, Director\, Diabetes Clinical Research\, Brigham and Women’s Hospital\, Harvard Medical School \nDr. Vanita Aroda is the Director of Diabetes Clinical Research at the Brigham and Women’s Hospital in Boston\, MA\, and is a Member of the Faculty of Harvard Medical School. \nDr. Aroda has an interest and published record in diabetes prevention and novel therapeutics in diabetes and weight management. She also has a strong interest in understanding therapeutic interventions in large Phase 3 and 4 clinical trials and their applicability and integration into care. Dr. Aroda has years of experience in clinical trial conduct and leadership\, has served as an investigator on the National Institutes of Health-funded GRADE\, D2d\, and DPPOS studies\, and as the national or international signatory Principal Investigator for several phase 3 clinical trials. \nMr. Amit Akkad\, ICC Director and Lifestyle Program Ambassador \nMr. Amit Akkad is an Experienced Global Services Executive\, currently working as VP of Operations at Ava Robotics with a proven track record of growing profitable service revenues with excellent customer satisfaction. Recognized as an IT services expert. A leader with excellent strategic\, analytical\, communications\, and operational skills. \nMr. Akkad is Director of ICC and Lifestyle Ambassador serving the community over the past couple of years. He also works with multiple organizations to educate and inspire children of rural communities (Adivasi) in India for the past few years. \n  \nResources \n\nCDC – On Your Way to Preventing Type 2 Diabetes \n\n\nAbout Prediabetics and Type 2 Diabetes 
URL:https://ouricc.org/event/preventing-type-2-diabetes-from-theory-to-reality/
LOCATION:Online
CATEGORIES:Health
ATTACH;FMTTYPE=image/png:https://ouricc.org/wp-content/uploads/2021/05/Preventing-Type2-Diabetes-16x9-1-960x350-1.png
END:VEVENT
END:VCALENDAR